Alaunos Therapeutics, Inc. Common Stock (TCRT) is a publicly traded Healthcare sector company. As of October 9, 2026, TCRT trades at $0.76 with a market cap of $1.98M and a P/E ratio of -0.39. TCRT moved +0.00% today. Year to date, TCRT is -76.04%; over the trailing twelve months it is -80.31%. Its 52-week range spans $0.72 to $6.20. Rallies surfaces TCRT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for TCRT combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $0.76 |
| Market Cap | $1.98M |
| P/E Ratio | -0.39 |
| EPS | $-2.20 |
| Dividend Yield | 0.00% |
| 52-Week High | $6.20 |
| 52-Week Low | $0.72 |
| Volume | 15.49K |
| Avg Volume | 0 |
| Revenue (TTM) | $5.00K |
| Net Income | $-4.18M |
| Gross Margin | 0.00% |
TCRT analyst coverage data. Average price target: $0.00.